Citations (290)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Yajing You, Tao Yang, Shuhang Wei, Zongxin Liu, Chenxi Liu, Zijian Shen, Yinuo Yang, Yuemin Feng, Ping Yao & Qiang Zhu. (2023) Survival of Patients with Hepatitis B-Related Hepatocellular Carcinoma with Concomitant Metabolic Associated Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 16, pages 2283-2293.
Read now
Read now
Naim Alkhouri & Samer Gawrieh. (2021) A perspective on RNA interference-based therapeutics for metabolic liver diseases. Expert Opinion on Investigational Drugs 30:3, pages 237-244.
Read now
Read now
Naim Alkhouri, Eric Lawitz, Mazen Noureddin, Ralph DeFronzo & Gerald I. Shulman. (2020) GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH). Expert Opinion on Investigational Drugs 29:2, pages 135-141.
Read now
Read now
Nathan W Sweeney, Cecil J Gomes, Richard De Armond, Sara M Centuori, Sairam Parthasarathy & Jesse D Martinez. (2019) Hypoxia Suppresses High Fat Diet-Induced Steatosis And Development Of Hepatic Adenomas. Hypoxia 7, pages 53-63.
Read now
Read now
Marta Iruarrizaga-Lejarreta, Enara Arretxe & Cristina Alonso. (2019) Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitis. Expert Review of Precision Medicine and Drug Development 4:5, pages 283-297.
Read now
Read now
Jake P. Mann, Massimiliano Raponi & Valerio Nobili. (2017) Clinical implications of understanding the association between oxidative stress and pediatric NAFLD. Expert Review of Gastroenterology & Hepatology 11:4, pages 371-382.
Read now
Read now
Robert H. Lustig. (2016) Fructose and Nonalcoholic Fatty Liver Disease. Journal of the California Dental Association 44:10, pages 613-617.
Read now
Read now
Briohny W. Smith & Leon A. Adams. (2011) Non-alcoholic fatty liver disease. Critical Reviews in Clinical Laboratory Sciences 48:3, pages 97-113.
Read now
Read now
Naim Alkhouri, Christine Carter-Kent, Michael Elias & Ariel Feldstein. (2011) Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. Clinical Lipidology 6:3, pages 305-314.
Read now
Read now
Carolin Lackner. (2011) Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspective. Expert Review of Gastroenterology & Hepatology 5:2, pages 223-231.
Read now
Read now
Naim Alkhouri, Christine Carter-Kent & Ariel E Feldstein. (2011) Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Review of Gastroenterology & Hepatology 5:2, pages 201-212.
Read now
Read now
Ann K Daly, Stefano Ballestri, Lucia Carulli, Paola Loria & Christopher P Day. (2011) Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 5:2, pages 253-263.
Read now
Read now
Articles from other publishers (278)
Simone Perna, Ayesha Rafique, Mariangela Rondanelli, Sabika Allehdan, Patrizia Riso & Mirko Marino. (2023) Effect of caper fruit (Capparis spinosa L.) consumption on liver enzymes, lipid profile, fasting plasma glucose, and weight loss. A systematic review and a preliminary meta-analysis of randomized controlled trials. Biomedicine & Pharmacotherapy 168, pages 115638.
Crossref
Crossref
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen & Shu-Ping Hui. (2023) Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease. Livers 3:4, pages 687-708.
Crossref
Crossref
Keisuke Sawada, Hak Chung, Samir Softic, Maria E. Moreno-Fernandez & Senad Divanovic. (2023) The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metabolism 35:11, pages 1852-1871.
Crossref
Crossref
Melinda H. SpoonerDonald B. Jump. (2023) Nonalcoholic Fatty Liver Disease and Omega-3 Fatty Acids: Mechanisms and Clinical Use. Annual Review of Nutrition 43:1, pages 199-223.
Crossref
Crossref
Dingyi Lin, Jiaqiang Zhou, Yang Cao, Ziyan Wang, Yi‐Cheng Hsu, Fenping Zheng, Hong Li, Shuiya Sun, Hong Ren, Liping Deng, Feng Chen & Min Wang. (2023)
Echo time optimization for in‐vivo measurement of unsaturated lipid resonances using J‐difference‐edited
MRS
. Magnetic Resonance in Medicine.
Crossref
Crossref
Qing Song, Jun Wang, Alexandra Griffiths, Samuel Man Lee, Iredia D. Iyamu, Rong Huang, Jose Cordoba-Chacon & Zhenyuan Song. (2023) Nicotinamide N-methyltransferase upregulation contributes to palmitate-elicited peroxisome proliferator-activated receptor transactivation in hepatocytes. American Journal of Physiology-Cell Physiology 325:1, pages C29-C41.
Crossref
Crossref
Peng Xie, Jin-Bo Xie, Man-Yu Xiao, Mei Guo, Yan-Shuang Qi, Fang-Fang Li & Xiang-Lan Piao. (2023) Liver lipidomics analysis reveals the anti-obesity and lipid-lowering effects of gypnosides from heat-processed Gynostemma pentaphyllum in high-fat diet fed mice. Phytomedicine 115, pages 154834.
Crossref
Crossref
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein JC. Kerbert, Francesco De Chiara, Rajiv Jalan & Hendrik Vilstrup. (2023) Role of ammonia in NAFLD: An unusual suspect. JHEP Reports 5:7, pages 100780.
Crossref
Crossref
Marion Régnier, Thaïs Carbinatti, Lucia Parlati, Fadila Benhamed & Catherine Postic. (2023) The role of ChREBP in carbohydrate sensing and NAFLD development. Nature Reviews Endocrinology 19:6, pages 336-349.
Crossref
Crossref
Archibold Mposhi, Fabian Cortés-Mancera, Janette Heegsma, Vincent E. de Meijer, Bart van de Sluis, Svenja Sydor, Lars P. Bechmann, Claudia Theys, Peter de Rijk, Tim De Pooter, Wim Vanden Berghe, İkbal Agah İnce, Klaas Nico Faber & Marianne G. Rots. (2023) Mitochondrial DNA methylation in metabolic associated fatty liver disease. Frontiers in Nutrition 10.
Crossref
Crossref
S. M. Touhidul Islam, Arun P. Palanisamy, Gabriel R. Chedister, Michael G. Schmidt, David N. B. Lewin & Kenneth D. Chavin. (2023) Unsaturated or saturated dietary fat-mediated steatosis impairs hepatic regeneration following partial hepatectomy in mice. PLOS ONE 18:5, pages e0284428.
Crossref
Crossref
Jialiu Zeng, Rebeca Acin-Perez, Essam A. Assali, Andrew Martin, Alexandra J. Brownstein, Anton Petcherski, Lucía Fernández-del-Rio, Ruiqing Xiao, Chih Hung Lo, Michaël Shum, Marc Liesa, Xue Han, Orian S. Shirihai & Mark W. Grinstaff. (2023) Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease. Nature Communications 14:1.
Crossref
Crossref
Scott A. Willis, Sundus Malaikah, Siôn Parry, Stephen Bawden, Gaël Ennequin, Jack A. Sargeant, Thomas Yates, David R. Webb, Melanie J. Davies, David J. Stensel, Guruprasad P. Aithal & James A. King. (2023) The effect of acute and chronic exercise on hepatic lipid composition. Scandinavian Journal of Medicine & Science in Sports 33:5, pages 550-568.
Crossref
Crossref
Tetsumori Yamashima, Yurie Mori, Takuya Seike, Sharif Ahmed, Piyakarn Boontem, Shihui Li, Shinji Oikawa, Hatasu Kobayashi, Tatsuya Yamashita, Mitsuru Kikuchi, Shuichi Kaneko & Eishiro Mizukoshi. (2023) Vegetable Oil-Peroxidation Product ‘Hydroxynonenal’ Causes Hepatocyte Injury and Steatosis via Hsp70.1 and BHMT Disorders in the Monkey Liver. Nutrients 15:8, pages 1904.
Crossref
Crossref
Lisa Rein-Fischboeck, Rebekka Pohl, Elisabeth M. Haberl, Wolfgang Mages, Philipp Girke, Gerhard Liebisch, Sabrina Krautbauer & Christa Buechler. (2023) Lower adiposity does not protect beta-2 syntrophin null mice from hepatic steatosis and inflammation in experimental non-alcoholic steatohepatitis. Gene 859, pages 147209.
Crossref
Crossref
Fides Regina Schwartz, Jeffrey Ashton, Benjamin Wildman-Tobriner, Lior Molvin, Juan Carlos Ramirez-Giraldo, Ehsan Samei, Mustafa Rifaat Bashir & Daniele Marin. (2023) Liver fat quantification in photon counting CT in head to head comparison with clinical MRI – First experience. European Journal of Radiology 161, pages 110734.
Crossref
Crossref
Miguel D. Ferrer, Clara Reynés, Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Josep A. Tur, Antoni Sureda & Antoni Pons. (2023) Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants 12:3, pages 711.
Crossref
Crossref
Wanbing Chen, Ruonan Liu, Xiaoling Zhu, Qun Lu, Hong Yang & Rui Liu. (2023) Microbial phenolic metabolites 3-(3′,4′-dihydroxyphenyl)propanoic acid and 3′,4′-dihydroxyphenylacetic acid prevent obesity in mice fed high-fat diet. Food Science and Human Wellness, pages 1-19.
Crossref
Crossref
Rohit Anthony Sinha. (2023) Autophagy: A Cellular Guardian against Hepatic Lipotoxicity. Genes 14:3, pages 553.
Crossref
Crossref
Akiko Eguchi, Motoh Iwasa & Hayato Nakagawa. (2022) Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets. Liver International 43:2, pages 292-298.
Crossref
Crossref
Pedro Barbosa & Eugenia Carvalho. (2023) Are Dietary Sugars Potent Adipose Tissue and Immune Cell Modulators?. Diabetology 4:1, pages 30-45.
Crossref
Crossref
Lucia Mráziková, Silvie Hojná, Petra Vaculová, Štěpán Strnad, Vladimír Vrkoslav, Helena Pelantová, Marek Kuzma, Blanka Železná, Jaroslav Kuneš & Lenka Maletínská. (2023) Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance. Nutrients 15:2, pages 280.
Crossref
Crossref
Emad Yuzbashian, Salma Moftah & Catherine B. Chan. (2023) Graduate Student Literature Review: A scoping review on the impact of consumption of dairy products on phosphatidylcholine and lysophosphatidylcholine in circulation and the liver in human studies and animal models. Journal of Dairy Science 106:1, pages 24-38.
Crossref
Crossref
Yi-fei Zhang, Yue Gao, Jie Yang, Yi-ming Jiang, Min Huang, Shi-cheng Fan & Hui-chang Bi. (2022) Long-term treatment with the mPXR agonist PCN promotes hepatomegaly and lipid accumulation without hepatocyte proliferation in mice. Acta Pharmacologica Sinica 44:1, pages 169-177.
Crossref
Crossref
Peter Lykke Eriksen, Karen Louise Thomsen, Stephen Hamilton-Dutoit, Hendrik Vilstrup & Michael Sørensen. (2022) Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved. BMC Gastroenterology 22:1.
Crossref
Crossref
Xiaolin Wang, Seung‐Jin Kim, Yukun Guan, Richard Parker, Robim M. Rodrigues, Dechun Feng, Shelly C. Lu & Bin Gao. (2022) Deletion of adipocyte prohibitin 1 exacerbates high‐fat diet‐induced steatosis but not liver inflammation and fibrosis. Hepatology Communications 6:12, pages 3335-3348.
Crossref
Crossref
Damien Chua, Zun Siong Low, Guo Xiang Cheam, Aik Seng Ng & Nguan Soon Tan. (2022) Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm. International Journal of Molecular Sciences 23:23, pages 14762.
Crossref
Crossref
Kai Wang, Jing Shi, Song Gao, Hui Hong, Yuqing Tan & Yongkang Luo. (2022) Oyster protein hydrolysates alleviated chronic alcohol-induced liver injury in mice by regulating hepatic lipid metabolism and inflammation response. Food Research International 160, pages 111647.
Crossref
Crossref
Haofei Hu, Yong Han, Changchun Cao & Yongcheng He. (2022) The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population. Journal of Translational Medicine 20:1.
Crossref
Crossref
Yan Xuan, Ping Gao, Ying Shen, Sujie Wang, Xi Gu, Dou Tang, Xun Wang, FanFan Zhu, Leiqun Lu & Ling Chen. (2022) Association of hypertriglyceridemic waist phenotype with non-alcoholic fatty liver disease: a cross-sectional study in a Chinese population. Hormones 21:3, pages 437-446.
Crossref
Crossref
Evangelia S. Makri, Eleftheria Makri & Stergios A. Polyzos. (2022) Combination Therapies for Nonalcoholic Fatty Liver Disease. Journal of Personalized Medicine 12:7, pages 1166.
Crossref
Crossref
Chao Huang, Xiaoli Wei, Qihui Luo, Yu Xia, Ting Pan, Junbo He, Asad Jahangir, Lanlan Jia, Wentao Liu, Yuanfeng Zou, Lixia Li, Hongrui Guo, Yi Geng & Zhengli Chen. (2022) Loss of TRIM67 Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 23:13, pages 7475.
Crossref
Crossref
Xingyue Chen, Li Zhang, Liming Zheng & Biguang Tuo. (2022)
Role of Ca
2+
channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review)
. International Journal of Molecular Medicine 50:3.
Crossref
Crossref
Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Sofía Montemayor, Catalina M. Mascaró, Miguel Casares, Isabel Llompart, José M. Gámez, Silvia Tejada, J. Alfredo Martínez, Josep A. Tur & Antoni Sureda. (2022) A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease. Antioxidants 11:7, pages 1266.
Crossref
Crossref
Xin Li, Jiaqiang Wang, LeYun Wang, Yuanxu Gao, Guihai Feng, Gen Li, Jun Zou, Meixin Yu, Yu Fei Li, Chao Liu, Xue Wei Yuan, Ling Zhao, Hong Ouyang, Jian-Kang Zhu, Wei Li, Qi Zhou & Kang Zhang. (2022) Lipid metabolism dysfunction induced by age-dependent DNA methylation accelerates aging. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Ana Teofilović, Miloš Vratarić, Nataša Veličković, Danijela Vojnović Milutinović, Aleksandra Mladenovic, Milica Prvulovic & Ana Djordjevic. (2022) Late-Onset Calorie Restriction Improves Lipid Metabolism and Aggravates Inflammation in the Liver of Old Wistar Rats. Frontiers in Nutrition 9.
Crossref
Crossref
Marija Branković, Igor Jovanović, Marija Dukić, Tijana Radonjić, Svetlana Oprić, Slobodan Klašnja & Marija Zdravković. (2022) Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 23:9, pages 5146.
Crossref
Crossref
Mathias B. Møllerhøj, Sanne S. Veidal, Kirstine Tølbøl Thrane, Denise Oró, Agnete Overgaard, Casper Gravesen Salinas, Martin Rønn Madsen, Larissa Pfisterer, Mogens Vyberg, Eric Simon, Andre Broermann, Niels Vrang, Jacob Jelsing, Michael Feigh & Henrik H. Hansen. (2022) Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH. Clinical and Translational Science 15:5, pages 1167-1186.
Crossref
Crossref
Geoffrey A. Dunn, A.J. Mitchell, Matthew Selby, Damien A. Fair, Hanna C. Gustafsson & Elinor L. Sullivan. (2022) Maternal diet and obesity shape offspring central and peripheral inflammatory outcomes in juvenile non-human primates. Brain, Behavior, and Immunity 102, pages 224-236.
Crossref
Crossref
Morgan Welch, Cassandra Secunda, Nabin Ghimire, Isabel Martinez, Amber Mathus, Urja Patel, Sarayu Bhogoju, Mashael Al-Mutairi, Kisuk Min & Ahmed Lawan. (2022) Characterization and Roles of Membrane Lipids in Fatty Liver Disease. Membranes 12:4, pages 410.
Crossref
Crossref
Ki Wung Chung, Ye Eun Cho, Seung-Jin Kim & Seonghwan Hwang. (2022) Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis. Archives of Pharmacal Research 45:4, pages 229-244.
Crossref
Crossref
Sara Guerra, Gabriele Mocciaro & Amalia Gastaldelli. (2021) Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non‐alcoholic steatohepatitis. European Journal of Clinical Investigation 52:3.
Crossref
Crossref
Yuta Matsubara, Hiroki Kiyohara, Toshiaki Teratani, Yohei Mikami & Takanori Kanai. (2022) Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases. Neuropharmacology 205, pages 108915.
Crossref
Crossref
C. Wittenbecher, R. Cuadrat, L. Johnston, F. Eichelmann, S. Jäger, O. Kuxhaus, M. Prada, F. Del Greco M.A. A. Hicks, P. Hoffman, J. Krumsiek, F. B. Hu & M. B. Schulze. (2022) Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology. Nature Communications 13:1.
Crossref
Crossref
越 张. (2022) Study on the Factors Related to Cholesterol Metabolism Pathway and Non-Alcoholic Fatty Liver Disease. Advances in Clinical Medicine 12:04, pages 3703-3709.
Crossref
Crossref
Robim M. Rodrigues, Yong He, Seonghwan Hwang, Adeline Bertola, Bryan Mackowiak, Yeni Ait Ahmed, Wonhyo Seo, Jing Ma, Xiaolin Wang, Seol Hee Park, Yukun Guan, Yaojie Fu, Tamara Vanhaecke, Dechun Feng & Bin Gao. (2022) E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9. Cellular and Molecular Gastroenterology and Hepatology 13:1, pages 151-171.
Crossref
Crossref
Joshua S. Wooten, Kaylee E. Poole, Matthew P. Harris, Brianne L. Guilford, Megan L. Schaller, David Umbaugh & Andrew Seija. (2022) The effects of voluntary wheel running during weight-loss on biomarkers of hepatic lipid metabolism and inflammation in C57Bl/6J mice. Current Research in Physiology 5, pages 63-72.
Crossref
Crossref
Jose A. Godoy-Lugo, Max A. Thorwald, David Y. Hui, Akira Nishiyama, Daisuke Nakano, Jose G. Soñanez-Organis & Rudy M. Ortiz. (2021) Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats. Endocrine 75:1, pages 92-107.
Crossref
Crossref
Sandra Abreu & Mário Sousa-Pimenta. 2022. Biomarkers in Nutrition. Biomarkers in Nutrition
745
766
.
Sandra Abreu & Mário Sousa-Pimenta. 2022. Biomarkers in Nutrition. Biomarkers in Nutrition
1
23
.
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone & Marcello Persico. (2021) Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Frontiers in Medicine 8.
Crossref
Crossref
Tiantian Xu, Qing Song, Li Zhou, Wenwen Yang, Xiangyao Wu, Qianyu Qian, Hui Chai, Qiang Han, Hongzhi Pan, Xiaobing Dou & Songtao Li. (2021) Ferulic acid alleviates lipotoxicity-induced hepatocellular death through the SIRT1-regulated autophagy pathway and independently of AMPK and Akt in AML-12 hepatocytes. Nutrition & Metabolism 18:1.
Crossref
Crossref
Elisabeth M. Haberl, Rebekka Pohl, Lisa Rein-Fischboeck, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch & Christa Buechler. (2021) Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice. Lipids in Health and Disease 20:1.
Crossref
Crossref
Jianan Zhao, Yiyang Hu & Jinghua Peng. (2021) Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy. Cellular & Molecular Biology Letters 26:1.
Crossref
Crossref
Scott A. Willis, Stephen J. Bawden, Sundus Malaikah, Jack A. Sargeant, David J. Stensel, Guruprasad P. Aithal & James A. King. (2021) The role of hepatic lipid composition in obesity‐related metabolic disease. Liver International 41:12, pages 2819-2835.
Crossref
Crossref
Mary Priyanka Udumula, Sureshbabu Mangali, Jaspreet Kalra, Deepika Dasari, Srashti Goyal, Vandana Krishna, Srivarsha Reddy Bollareddy, Dharamrajan Sriram, Arti Dhar & Audesh Bhat. (2021) High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats. Scientific Reports 11:1.
Crossref
Crossref
Soumalya Sarkar, Deepika Kumari, Sonu Kumar Gupta, Vipin Sharma, Sumedha Mukhi, Parul Kamboj, Vedula Sasibhushan, Rajiva Kumar Rai, Sastry Lakshminarayana Jatavallabhula, Dinesh Mahajan, Yashwant Kumar, Ajay Kumar & Madhu Dikshit. (2021) Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. Biomedicine & Pharmacotherapy 144, pages 112357.
Crossref
Crossref
Stanislav Kotlyarov & Aleksei Bulgakov. (2021) Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. Cells 10:11, pages 2978.
Crossref
Crossref
Jitka Starekova, Diego Hernando, Perry J. Pickhardt & Scott B. Reeder. (2021) Quantification of Liver Fat Content with CT and MRI: State of the Art. Radiology 301:2, pages 250-262.
Crossref
Crossref
Mario Alberto Burgos Aceves, Vincenzo Migliaccio, Marilena Lepretti, Gaetana Paolella, Ilaria Di Gregorio, Serena Penna, Caterina Faggio & Lillà Lionetti. (2021) Dose-Dependent Response to the Environmental Pollutant Dichlorodipheniletylhene (DDE) in HepG2 Cells: Focus on Cell Viability and Mitochondrial Fusion/Fission Proteins. Toxics 9:11, pages 270.
Crossref
Crossref
Ting Yao, Xu Gu, Xiaofang Liang, Fatou Ndoye Fall, Aizhi Cao, Songshan Zhang, Ying Guan, Baozhong Sun & Min Xue. (2021) Tolerance assessment of dietary bile acids in common carp (Cyprinus carpio L.) fed a high plant protein diet. Aquaculture 543, pages 737012.
Crossref
Crossref
Asmita Pant, Yue Chen, Annapurna Kuppa, Xiaomeng Du, Brian D. Halligan & Elizabeth K. Speliotes. (2021) Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line. International Journal of Molecular Sciences 22:18, pages 9758.
Crossref
Crossref
Roi Isaac, Felipe Castellani Gomes Reis, Wei Ying & Jerrold M. Olefsky. (2021) Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metabolism 33:9, pages 1744-1762.
Crossref
Crossref
Huicui Liu, Tao Chen, Xiaoqing Xie, Xinlei Wang, Yiwen Luo, Nan Xu, Zhen Sa, Min Zhang, Zhifei Chen, Xinzhong Hu & Juxiu Li. (2021) Hepatic Lipidomics Analysis Reveals the Ameliorative Effects of Highland Barley β-Glucan on Western Diet-Induced Nonalcoholic Fatty Liver Disease Mice. Journal of Agricultural and Food Chemistry 69:32, pages 9287-9298.
Crossref
Crossref
Kendra K. Bence & Morris J. Birnbaum. (2021) Metabolic drivers of non-alcoholic fatty liver disease. Molecular Metabolism 50, pages 101143.
Crossref
Crossref
Shiwei Chen, Huiting Guo, Mingjie Xie, Cheng Zhou & Min Zheng. (2021) Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease. International Immunopharmacology 97, pages 107609.
Crossref
Crossref
Tagreed A. Mazi, Kamil Borkowski, John W. Newman, Oliver Fiehn, Christopher L. Bowlus, Souvik Sarkar, Karen Matsukuma, Mohamed R. Ali, Dorothy A. Kieffer, Yu-Jui Y. Wan, Kimber L. Stanhope, Peter J. Havel & Valentina Medici. (2021) Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study. Free Radical Biology and Medicine 172, pages 490-502.
Crossref
Crossref
Biljana Atanasovska, Sander S. Rensen, Glenn Marsman, Ronit Shiri-Sverdlov, Sebo Withoff, Folkert Kuipers, Cisca Wijmenga, Bart van de Sluis & Jingyuan Fu. (2021) Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis. Cells 10:8, pages 1883.
Crossref
Crossref
Anna Di Sessa, Simona Riccio, Emilia Pirozzi, Martina Verde, Antonio Paride Passaro, Giuseppina Rosaria Umano, Stefano Guarino, Emanuele Miraglia del Giudice & Pierluigi Marzuillo. (2021) Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics. World Journal of Gastroenterology 27:25, pages 3815-3824.
Crossref
Crossref
Seyedeh Alemeh Hosseinian & Fereshteh Hasanzadeh. (2021) Impact of high dietary energy on obesity and oxidative stress in domestic pigeons. Veterinary Medicine and Science 7:4, pages 1391-1399.
Crossref
Crossref
Seyeon Oh, Myeongjoo Son, Kyung-A Byun, Ji Tae Jang, Chang Hu Choi, Kuk Hui Son & Kyunghee Byun. (2021) Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis. Marine Drugs 19:6, pages 318.
Crossref
Crossref
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao & Suchart Kothan. (2021) Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 11:5, pages 842.
Crossref
Crossref
Grace Park, Sunhee Jung, Kathryn E. Wellen & Cholsoon Jang. (2021) The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease. Experimental & Molecular Medicine 53:5, pages 809-822.
Crossref
Crossref
Danijela Vojnović Milutinović, Ana Teofilović, Nataša Veličković, Jelena Brkljačić, Sanja Jelača, Ana Djordjevic & Djuro Macut. (2021) Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome. Endocrine 72:2, pages 562-572.
Crossref
Crossref
Cheng Hu, Tao Wang, Xiaoyu Zhuang, Qiaoli Sun, Xiaochun Wang, Hui Lin, Mingli Feng, Jiaqi Zhang, Qin Cao & Yuanye Jiang. (2021) Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry. Journal of Translational Medicine 19:1.
Crossref
Crossref
Maria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, Pasqua Letizia Pesole, Antonio Lippolis, Valeria Tutino, Caterina Bonfiglio, Valentina De Nunzio, Maria Principia Scavo, Antonella Mirizzi, Isabella Franco, Tamara Lippolis, Rosalba D’Alessandro, Maria Grazia Refolo & Caterina Messa. (2021) Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. International Journal of Molecular Sciences 22:8, pages 3899.
Crossref
Crossref
Chenzhipeng Nie, Yan Li, Yanming Guan, Kuiliang Zhang, Jinxin Liu, Mingcong Fan, Haifeng Qian & Li Wang. (2021) Highland barley tea represses palmitic acid-induced apoptosis and mitochondrial dysfunction via regulating AMPK/SIRT3/FoxO3a in myocytes. Food Bioscience 40, pages 100893.
Crossref
Crossref
Hiroyuki Kurata. (2021) Virtual metabolic human dynamic model for pathological analysis and therapy design for diabetes. iScience 24:2, pages 102101.
Crossref
Crossref
Johanna C. Arroyave-Ospina, Zongmei Wu, Yana Geng & Han Moshage. (2021) Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy. Antioxidants 10:2, pages 174.
Crossref
Crossref
Daiane T. Oliveira, Adriano B. Chaves-Filho, Marcos Y. Yoshinaga, Nívia Carolina N. Paiva, Cláudia M. Carneiro, Sayuri Miyamoto, William T. Festuccia & Renata Guerra-Sá. (2021) Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar diet. The Journal of Nutritional Biochemistry 87, pages 108519.
Crossref
Crossref
Olga Vvedenskaya, Tim Daniel Rose, Oskar Knittelfelder, Alessandra Palladini, Judith Andrea Heidrun Wodke, Kai Schuhmann, Jacobo Miranda Ackerman, Yuting Wang, Canan Has, Mario Brosch, Veera Raghavan Thangapandi, Stephan Buch, Thomas Züllig, Jürgen Hartler, Harald C. Köfeler, Christoph Röcken, Ünal Coskun, Edda Klipp, Witigo von Schoenfels, Justus Gross, Clemens Schafmayer, Jochen Hampe, Josch Konstantin Pauling & Andrej Shevchenko. (2021) Nonalcoholic fatty liver disease stratification by liver lipidomics. Journal of Lipid Research 62, pages 100104.
Crossref
Crossref
Fariha Kabir, Kamrun Nahar, Md. Mizanur Rahman, Fariha Mamun, Shoumen Lasker, Ferdous Khan, Tahmina Yasmin, Khondker Ayesha Akter, Nusrat Subhan & Md. Ashraful Alam. (2020) Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet–fed rats. Naunyn-Schmiedeberg's Archives of Pharmacology 394:1, pages 33-47.
Crossref
Crossref
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, Simon S. Evers, Sara Heebøll, Peter Lykke Eriksen, Karen Louise Thomsen, Anja Bengtsson, Sanne S. Veidal, Michel Feigh, Malte P. Suppli, Filip K. Knop, Henning Grønbæk, Diego Miranda, James L. Trevaskis, Niels Vrang, Jacob Jelsing & Kristoffer T. G. Rigbolt. (2020) Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. BMC Gastroenterology 20:1.
Crossref
Crossref
Yedidya Saiman, Royce Hooks & Rotonya M. Carr. (2020) High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and Progression. Current Hepatology Reports 19:4, pages 412-419.
Crossref
Crossref
Jason Szuhao Yang, Jozxelle Tongson, Kee-Hong Kim & Yeonhwa Park. (2020) Piceatannol attenuates fat accumulation and oxidative stress in steatosis-induced HepG2 cells. Current Research in Food Science 3, pages 92-99.
Crossref
Crossref
Regina Ngozi Ugbaja, Oluwasegun Micheal Okedairo, Adejare Rasaq Oloyede, Emmanuel Ifeanyichukwu Ugwor, Dorcas Ibukun Akinloye, Olusola Peter Ojo & Oladipo Ademuyiwa. (2020) Probiotics consortium synergistically ameliorates aflatoxin B1-induced disruptions in lipid metabolism of female albino rats. Toxicon 186, pages 109-119.
Crossref
Crossref
Michelle T. Long, Sanil Gandhi & Rohit Loomba. (2020) Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Metabolism 111, pages 154259.
Crossref
Crossref
Cai-Yu Lian, Zhen-Zhen Zhai, Zi-Fa Li & Lin Wang. (2020) High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 330, pages 109199.
Crossref
Crossref
Monica A. Tincopa. (2020) Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis. Endocrinology, Diabetes & Metabolism 3:4.
Crossref
Crossref
Christiane Rennert, Theresa Heil, Gerda Schicht, Anna Stilkerich, Lena Seidemann, Victoria Kegel-Hübner, Daniel Seehofer & Georg Damm. (2020) Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress. International Journal of Molecular Sciences 21:19, pages 7097.
Crossref
Crossref
Sandra Steensels, Jixuan Qiao, Yanzhen Zhang, Kristal M. Maner‐Smith, Nourhan Kika, Corey D. Holman, Kathleen E. Corey, W. Clay Bracken, Eric A. Ortlund & Baran A. Ersoy. (2020) Acyl‐Coenzyme A Thioesterase 9 Traffics Mitochondrial Short‐Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver. Hepatology 72:3, pages 857-872.
Crossref
Crossref
Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Manuela Abbate, Sofía Montemayor, Catalina M. Mascaró, Miguel Casares, Silvia Tejada, Itziar Abete, Maria Angeles Zulet, Josep A. Tur, J. Alfredo Martínez & Antoni Sureda. (2020) Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants 9:8, pages 759.
Crossref
Crossref
Annelise M. Poss & Scott A. Summers. (2020) Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD. Frontiers in Endocrinology 11.
Crossref
Crossref
Ke Pei, Ting Gui, Dongfang Kan, Huichao Feng, Yanqiang Jin, Ying Yang, Qian Zhang, Ziwei Du, Zhibo Gai, Jibiao Wu & Yunlun Li. (2020) An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease. BioMed Research International 2020, pages 1-12.
Crossref
Crossref
Benjamin Jenkins, Martin Ronis & Albert Koulman. (2020) LC–MS Lipidomics: Exploiting a Simple High-Throughput Method for the Comprehensive Extraction of Lipids in a Ruminant Fat Dose-Response Study. Metabolites 10:7, pages 296.
Crossref
Crossref
Yifeng Wang, Sumedha Gunewardena, Feng Li, David J. Matye, Cheng Chen, Xiaojuan Chao, Taeyoon Jung, Yuxia Zhang, Maciej Czerwiński, Hong-Min Ni, Wen-Xing Ding & Tiangang Li. (2020) An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis. Nature Communications 11:1.
Crossref
Crossref
Yongyan Chen & Zhigang Tian. (2020) Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis. Frontiers in Immunology 11.
Crossref
Crossref
Marion Duriez, Agnes Jacquet, Lucile Hoet, Sandrine Roche, Marie-Dominique Bock, Corinne Rocher, Gilles Haussy, Xavier Vigé, Zsolt Bocskei, Tamara Slavnic, Valérie Martin, Jean-Claude Guillemot, Michel Didier, Aimo Kannt, Cécile Orsini, Vincent Mikol & Anne-Céline Le Fèvre. (2020) A 3D Human Liver Model of Nonalcoholic Steatohepatitis. Journal of Clinical and Translational Hepatology 8:3, pages 1-12.
Crossref
Crossref
Naoki Takatani, Yuka Kono, Fumiaki Beppu, Yuko Okamatsu-Ogura, Yumiko Yamano, Kazuo Miyashita & Masashi Hosokawa. (2020) Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. Biochemical and Biophysical Research Communications 528:2, pages 305-310.
Crossref
Crossref
Danijela Vojnović Milutinović, Jelena Brkljačić, Ana Teofilović, Biljana Bursać, Marina Nikolić, Ljupka Gligorovska, Sanja Kovačević, Ana Djordjevic, Frederic Preitner, Luc Tappy, Gordana Matić & Nataša Veličković. (2020) Chronic Stress Potentiates High Fructose–Induced Lipogenesis in Rat Liver and Kidney. Molecular Nutrition & Food Research 64:13.
Crossref
Crossref
Alice E. PollardDavid Carling. (2020) Thermogenic adipocytes: lineage, function and therapeutic potential. Biochemical Journal 477:11, pages 2071-2093.
Crossref
Crossref
Divya P. Kumar, Rebecca Caffrey, Jonathon Marioneaux, Prasanna K. Santhekadur, Madhavi Bhat, Cristina Alonso, Srinivas V. Koduru, Binu Philip, Mukul R. Jain, Suresh R. Giri, Pierre Bedossa & Arun J. Sanyal. (2020) The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease. Scientific Reports 10:1.
Crossref
Crossref
Ewelina Matuszyk, Ewa Sierka, Marko Rodewald, Hyeonsoo Bae, Tobias Meyer, Edyta Kus, Stefan Chlopicki, Michael Schmitt, Jürgen Popp & Malgorzata Baranska. (2020) Differential response of liver sinusoidal endothelial cells and hepatocytes to oleic and palmitic acid revealed by Raman and CARS imaging. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:6, pages 165763.
Crossref
Crossref
Simon Bucher, Karima Begriche, Daniel Catheline, Viviane Trak-Smayra, François Tiaho, Cédric Coulouarn, Grégory Pinon, Dominique Lagadic-Gossmann, Vincent Rioux & Bernard Fromenty. (2019) Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids. European Journal of Nutrition 59:4, pages 1619-1632.
Crossref
Crossref
María Correa-Rodríguez, Gabriela Pocovi-Gerardino, José-Luis Callejas-Rubio, Raquel Ríos Fernández, María Martín-Amada, María-Gracia Cruz-Caparros, Irene Medina-Martínez, Norberto Ortego-Centeno & Blanca Rueda-Medina. (2020) Dietary Intake of Free Sugars is Associated with Disease Activity and Dyslipidemia in Systemic Lupus Erythematosus Patients. Nutrients 12:4, pages 1094.
Crossref
Crossref
Deolinda Santinha, Anna Klopot, Igor Marques, Ewa Ellis, Carl Jorns, Helene Johansson, Tânia Melo, Per Antonson, Tomas Jakobsson, Vítor Félix, Jan-Åke Gustafsson, Maria Rosário Domingues, Agneta Mode & Luisa A. Helguero. (2020) Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine. The Journal of Steroid Biochemistry and Molecular Biology 198, pages 105558.
Crossref
Crossref
Melissa M. Heintz, Rebecca McRee, Ramiya Kumar & William S. Baldwin. (2020) Gender differences in diet-induced steatotic disease in Cyp2b-null mice. PLOS ONE 15:3, pages e0229896.
Crossref
Crossref
Fernando Bril, Diana Barb, Romina Lomonaco, Jinping Lai & Kenneth Cusi. (2020) Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis. Journal of Hepatology 72:3, pages 401-410.
Crossref
Crossref
Xin LiJiaqiang WangLeyun WangGuihai FengGen LiMeixin YuYufei LiChao LiuXuewei YuanGuangxi ZangZhihuan LiLing ZhaoHong OuyangQingli QuanGuangyu WangCharlotte ZhangOulan LiJunkai XiangJian-Kang Zhu, Wei LiQi ZhouKang Zhang. (2020) Impaired lipid metabolism by age-dependent DNA methylation alterations accelerates aging. Proceedings of the National Academy of Sciences 117:8, pages 4328-4336.
Crossref
Crossref
Kai Wang, Chuanjiang Li, Xinxin Lin, Hang Sun, Ruijuan Xu, Qingping Li, Yiran Wei, Yiyi Li, Jianping Qian, Cuiting Liu, Qifan Zhang, Sheng Yu, Zhonglin Cui, Xixin Huang, Bili Zhu, Jie Zhou & Cungui Mao. (2020) Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress. Cell Death & Disease 11:1.
Crossref
Crossref
Anastasia P. Nesterova, Eugene A. Klimov, Maria Zharkova, Sergey Sozin, Vladimir Sobolev, Natalia V. Ivanikova, Maria Shkrob & Anton Yuryev. 2020. Disease Pathways. Disease Pathways
443
491
.
Wei Zhu, Meihua Zhang, Liming Chang, Wenbo Zhu, Cheng Li, Feng Xie, Huan Zhang, Tian Zhao & Jianping Jiang. (2019) Characterizing the composition, metabolism and physiological functions of the fatty liver in Rana omeimontis tadpoles. Frontiers in Zoology 16:1.
Crossref
Crossref
S.‐M. Jeong, H. Kwon, S. Park, S. J. Yu, H.‐Y. Jeong, K.‐W. Nam, H.‐M. Kwon & J.‐H. Park. (2019) Favorable impact of non‐alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy population. European Journal of Neurology 26:12, pages 1471-1478.
Crossref
Crossref
Bernard Fromenty. (2019) Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis. Liver Research 3:3-4, pages 157-169.
Crossref
Crossref
Huanhuan Yu, Lulu Zhang, Pei Chen, Xiaofang Liang, Aizhi Cao, Juan Han, Xiufeng Wu, Yinhua Zheng, Yuchang Qin & Min Xue. (2019) Dietary Bile Acids Enhance Growth, and Alleviate Hepatic Fibrosis Induced by a High Starch Diet via AKT/FOXO1 and cAMP/AMPK/SREBP1 Pathway in Micropterus salmoides. Frontiers in Physiology 10.
Crossref
Crossref
Desterke & Chiappini. (2019) Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway. International Journal of Molecular Sciences 20:22, pages 5594.
Crossref
Crossref
Zahra Safari, Magali Monnoye, Peter M. Abuja, Mahendra Mariadassou, Karl Kashofer, Philippe Gérard & Kurt Zatloukal. (2019) Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration. Nutrition Research 71, pages 72-88.
Crossref
Crossref
Melissa L. Erickson, Jacob M. Haus, Steven K. Malin, Chris A. Flask, Arthur J. McCullough & John P. Kirwan. (2019) Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype. Nutrition, Metabolism and Cardiovascular Diseases 29:11, pages 1197-1204.
Crossref
Crossref
Gianluca Svegliati-Baroni, Irene Pierantonelli, Pierangelo Torquato, Rita Marinelli, Carla Ferreri, Chryssostomos Chatgilialoglu, Desirée Bartolini & Francesco Galli. (2019) Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. Free Radical Biology and Medicine 144, pages 293-309.
Crossref
Crossref
Scott A. Summers, Bhagirath Chaurasia & William L. Holland. (2019) Metabolic Messengers: ceramides. Nature Metabolism 1:11, pages 1051-1058.
Crossref
Crossref
Yang Zhang, Chenchen Li, Chuanzhen Hu, Qian Wu, Yongping Cai, Songge Xing, Hui Lu, Lin Wang, De Huang, Linchong Sun, Tingting Li, Xiaoping He, Xiuying Zhong, Junfeng Wang, Ping Gao, Zachary J Smith, Weidong Jia & Huafeng Zhang. (2019)
Lin28 enhances
de novo
fatty acid synthesis to promote cancer progression via
SREBP
‐1
. EMBO reports 20:10.
Crossref
Crossref
Lu‐yang Ding, Li‐zong Liang, Yong‐xu Zhao, Ya‐nan Yang, Feng Liu, Qiu‐rong Ding & Li‐jun Luo. (2019)
Porphyromonas gingivalis
‐derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF‐κB and JNK signaling pathways
. Oral Diseases 25:7, pages 1789-1797.
Crossref
Crossref
Konstantinos Kounakis, Manos Chaniotakis, Maria Markaki & Nektarios Tavernarakis. (2019) Emerging Roles of Lipophagy in Health and Disease. Frontiers in Cell and Developmental Biology 7.
Crossref
Crossref
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis & Henrik H Hansen. (2019) Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World Journal of Gastroenterology 25:33, pages 4904-4920.
Crossref
Crossref
Yunes Panahi, Ghasem Valizadegan, Nobakht Ahamdi, Shiva Ganjali, Muhammed Majeed & Amirhossein Sahebkar. (2019) Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial. Journal of Cellular Biochemistry 120:9, pages 15989-15996.
Crossref
Crossref
Logan K. Townsend, Kyle D. Medak, Willem T. Peppler, Grace M. Meers, R. Scott Rector, Paul J. LeBlanc & David C. Wright. (2019) High-saturated-fat diet-induced obesity causes hepatic interleukin-6 resistance via endoplasmic reticulum stress. Journal of Lipid Research 60:7, pages 1236-1249.
Crossref
Crossref
Rimsha Munir, Jan Lisec, Johannes V. Swinnen & Nousheen Zaidi. (2019) Lipid metabolism in cancer cells under metabolic stress. British Journal of Cancer 120:12, pages 1090-1098.
Crossref
Crossref
In Cheol Yoon & Jong Ryeol Eun. (2019) Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology. Yeungnam University Journal of Medicine 36:2, pages 67-77.
Crossref
Crossref
Chanbin Lee, Jieun Kim, Sihyung Wang, Sumi Sung, Namgyu Kim, Hyun-Hee Lee, Young-Su Seo & Youngmi Jung. (2019) Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 20:9, pages 2369.
Crossref
Crossref
Seung‐Jin Kim, Dechun Feng, Adrien Guillot, Shen Dai, Fengming Liu, Seonghwan Hwang, Richard Parker, Wonhyo Seo, Yong He, Grzegorz Godlewski, Won‐Il Jeong, Yuhong Lin, Xuebin Qin, George Kunos & Bin Gao. (2019) Adipocyte Death Preferentially Induces Liver Injury and Inflammation Through the Activation of Chemokine (C‐C Motif) Receptor 2‐Positive Macrophages and Lipolysis. Hepatology 69:5, pages 1965-1982.
Crossref
Crossref
Marion Régnier, Arnaud Polizzi, Hervé Guillou & Nicolas Loiseau. (2019) Sphingolipid metabolism in non-alcoholic fatty liver diseases. Biochimie 159, pages 9-22.
Crossref
Crossref
Ewelina Szafraniec, Edyta Kus, Adrianna Wislocka, Bozena Kukla, Ewa Sierka, Valérie Untereiner, Ganesh D. Sockalingum, Stefan Chlopicki & Malgorzata Baranska. (2019) Raman spectroscopy–based insight into lipid droplets presence and contents in liver sinusoidal endothelial cells and hepatocytes. Journal of Biophotonics 12:4.
Crossref
Crossref
Shiyin Lu, Rigang Lu, Hui Song, Jinxia Wu, Xuwen Liu, Xiaoling Zhou, Jianqing Yang, Hongye Zhang, Chaoling Tang, Hongwei Guo, Jian Hu, Guifu Mao, Hanmei Lin, Zhiheng Su & Hua Zheng. (2019) Metabolomic study of natrin-induced apoptosis in SMMC-7721 hepatocellular carcinoma cells by ultra-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry. International Journal of Biological Macromolecules 124, pages 1264-1273.
Crossref
Crossref
Irene Pierantonelli & Gianluca Svegliati-Baroni. (2019) Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. Transplantation 103:1, pages e1-e13.
Crossref
Crossref
Yoojin Lee & Ji-Young Lee. 2019. Dietary Interventions in Liver Disease. Dietary Interventions in Liver Disease
91
99
.
Dominika Maciejewska, Wojciech Marlicz, Karina Ryterska, Marcin Banaszczak, Dominika Jamioł-Milc & Ewa Stachowska. (2018) Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD). Canadian Journal of Gastroenterology and Hepatology 2018, pages 1-8.
Crossref
Crossref
Victoria Svop Jensen, Henning Hvid, Jesper Damgaard, Helle Nygaard, Camilla Ingvorsen, Erik Max Wulff, Jens Lykkesfeldt & Christian Fledelius. (2018) Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague–Dawley rats. Diabetology & Metabolic Syndrome 10:1.
Crossref
Crossref
Mustafa T. Ardah, Shama Parween, Divya S. Varghese, Bright Starling Emerald & Suraiya A. Ansari. (2018) Saturated fatty acid alters embryonic cortical neurogenesis through modulation of gene expression in neural stem cells. The Journal of Nutritional Biochemistry 62, pages 230-246.
Crossref
Crossref
Mariana Nikolova-Karakashian. (2018) Alcoholic and non-alcoholic fatty liver disease: Focus on ceramide. Advances in Biological Regulation 70, pages 40-50.
Crossref
Crossref
Yang Yang, Jingjing Wang, Yongmin Zhang, Jing Li & Wenji Sun. (2018) Black Sesame Seeds Ethanol Extract Ameliorates Hepatic Lipid Accumulation, Oxidative Stress, and Insulin Resistance in Fructose-Induced Nonalcoholic Fatty Liver Disease. Journal of Agricultural and Food Chemistry 66:40, pages 10458-10469.
Crossref
Crossref
Miriam G. Shtriker, Irena Peri, Elise Taieb, Abraham Nyska, Oren Tirosh & Zecharia Madar. (2018) Galactomannan More than Pectin Exacerbates Liver Injury in Mice Fed with High‐Fat, High‐Cholesterol Diet. Molecular Nutrition & Food Research 62:20.
Crossref
Crossref
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, Patrick R. Varley, Julie Goswami, Hamza O. Yazdani, Samer Tohme, Patricia Loughran, Robert M. O'Doherty, Marta I. Minervini, Hai Huang, Richard L. Simmons & Allan Tsung. (2018) Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology 68:4, pages 1347-1360.
Crossref
Crossref
Andrey Turchinovich, Ancha Baranova, Oksana Drapkina & Alexander Tonevitsky. (2018) Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Frontiers in Physiology 9.
Crossref
Crossref
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke & Robim M. Rodrigues. (2018) Human-based systems: Mechanistic NASH modelling just around the corner?. Pharmacological Research 134, pages 257-267.
Crossref
Crossref
Tae Woo Jung, Changmuk Kang, Jiwon Goh, Soo In Chae, Hyoung‐Chun Kim, Tae Jin Lee, A.M. Abd El‐Aty & Ji Hoon Jeong. (2018) WISP1 promotes non‐alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling. Journal of Cellular Physiology 233:8, pages 6077-6087.
Crossref
Crossref
Nahum Mendez-Sanchez, Vania Cruz-Ramon, Oscar Ramirez-Perez, Jessica Hwang, Beatriz Barranco-Fragoso & Jaqueline Cordova-Gallardo. (2018) New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 19:7, pages 2034.
Crossref
Crossref
Elena Meidan, Yula Kolesnikov & Oren Tirosh. (2018) High Fat Diets Composed of Palm Stearin and Olive Oil Equally Exacerbate Liver Inflammatory Damage and Metabolic Stress in Mice. Molecular Nutrition & Food Research 62:13, pages 1700915.
Crossref
Crossref
Naim Alkhouri, Fred Poordad & Eric Lawitz. (2018) Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes. Hepatology Communications 2:7, pages 778-785.
Crossref
Crossref
Oren Tirosh. (2018) Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. Oxidative Medicine and Cellular Longevity 2018, pages 1-15.
Crossref
Crossref
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, Allan Tsung & Hai Huang. (2018) The Effects of Physical Exercise on Fatty Liver Disease. Gene Expression 18:2, pages 89-101.
Crossref
Crossref
Karen Della Corte, Ines Perrar, Katharina Penczynski, Lukas Schwingshackl, Christian Herder & Anette Buyken. (2018) Effect of Dietary Sugar Intake on Biomarkers of Subclinical Inflammation: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients 10:5, pages 606.
Crossref
Crossref
Jay V. Patankar, Chi K. Wong, Vijay Morampudi, William T. Gibson, Bruce Vallance, George N. Ioannou & Michael R. Hayden. (2018)
Genetic ablation of
Cyp8b1
preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition
. American Journal of Physiology-Endocrinology and Metabolism 314:5, pages E418-E432.
Crossref
Crossref
Lynn Ebner, Anne Gläser, Anja Bräuer, Martin Witt, Andreas Wree, Arndt Rolfs, Marcus Frank, Brigitte Vollmar & Angela Kuhla. (2018) Evaluation of Two Liver Treatment Strategies in a Mouse Model of Niemann–Pick-Disease Type C1. International Journal of Molecular Sciences 19:4, pages 972.
Crossref
Crossref
Ian James Martins. 2018. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment.
Akiko Eguchi & Ariel E. Feldstein. (2018) Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases. Liver Research 2:1, pages 30-34.
Crossref
Crossref
Martine C. Morrison, Robert Kleemann, Arianne van Koppen, Roeland Hanemaaijer & Lars Verschuren. (2018) Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study. Frontiers in Physiology 9.
Crossref
Crossref
Nurulain Ho, Chengchao Xu & Guillaume Thibault. (2018) From the unfolded protein response to metabolic diseases – lipids under the spotlight. Journal of Cell Science 131:3.
Crossref
Crossref
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner & Sasmita Tripathy. (2018) Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacology & Therapeutics 181, pages 108-125.
Crossref
Crossref
Mariana Nikolova-Karakashian. 2018. Sphingolipids in Cancer. Sphingolipids in Cancer
155
190
.
Mariana Verdelho Machado & Anna Mae Diehl. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
369
390.e14
.
Abdul M. Oseini, Banumathi K. Cole, Danny Issa, Ryan E. Feaver & Arun J. Sanyal. (2018) Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis. Hepatology International 12:1, pages 6-16.
Crossref
Crossref
Geoffrey C. Farrell, Fahrettin Haczeyni & Shivakumar Chitturi. 2018. Obesity, Fatty Liver and Liver Cancer. Obesity, Fatty Liver and Liver Cancer
19
44
.
Baran A. Ersoy, Kristal M. Maner-Smith, Yingxia Li, Ipek Alpertunga & David E. Cohen. (2017) Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress. Journal of Clinical Investigation 128:1, pages 141-156.
Crossref
Crossref
Yael Ben-Harosh, Mariana Anosov, Hagit Salem, Yekaterina Yatchenko & R. Birk. (2017) Pancreatic stellate cell activation is regulated by fatty acids and ER stress. Experimental Cell Research 359:1, pages 76-85.
Crossref
Crossref
Francesco Bellanti, Rosanna Villani, Antonio Facciorusso, Gianluigi Vendemiale & Gaetano Serviddio. (2017) Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. Free Radical Biology and Medicine 111, pages 173-185.
Crossref
Crossref
Ana Francisca Soares, Jonathan Paz-Montoya, Hongxia Lei, Marc Moniatte & Rolf Gruetter. (2017) Sexual dimorphism in hepatic lipids is associated with the evolution of metabolic status in mice. NMR in Biomedicine 30:10, pages e3761.
Crossref
Crossref
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola & Antoni Caimari. (2017) Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 9:10, pages 1052.
Crossref
Crossref
Sébastien Lepreux, Julien Villeneuve, Antoine Dewitte, Annie M. Bérard, Alexis Desmoulière & Jean Ripoche. (2017) CD40 signaling and hepatic steatosis: Unanticipated links. Clinics and Research in Hepatology and Gastroenterology 41:4, pages 357-369.
Crossref
Crossref
Takahiro Nishio, Kojiro Taura, Keiko Iwaisako, Yukinori Koyama, Kazutaka Tanabe, Gen Yamamoto, Yukihiro Okuda, Yoshinobu Ikeno, Kenji Yoshino, Yosuke Kasai, Masayuki Okuno, Satoru Seo, Takaki Sakurai, Masataka Asagiri, Etsuro Hatano & Shinji Uemoto. (2017) Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis. Journal of Gastroenterology 52:8, pages 965-976.
Crossref
Crossref
Hiroyuki Akai, Shigeru Kiryu, Yasunori Ohta, Koichiro Yasaka, Yoshiyasu Nakano, Yusuke Inoue & Kuni Ohtomo. (2017) The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice. Magnetic Resonance Imaging 38, pages 123-128.
Crossref
Crossref
Yo Muraki, Yukimasa Makita, Midori Yamasaki, Yuichiro Amano & Takanori Matsuo. (2017) Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l -amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model. Biochemical and Biophysical Research Communications 486:3, pages 632-638.
Crossref
Crossref
T. Houben, E. Brandsma, S.M.A. Walenbergh, M.H. Hofker & R. Shiri-Sverdlov. (2017) Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1862:4, pages 416-429.
Crossref
Crossref
K. Kochan, Malgorzata Baranska & E. Maslak. 2007. Encyclopedia of Analytical Chemistry. Encyclopedia of Analytical Chemistry
1
24
.
Stefania Cannito, Elisabetta Morello, Claudia Bocca, Beatrice Foglia, Elisa Benetti, Erica Novo, Fausto Chiazza, Mara Rogazzo, Roberto Fantozzi, Davide Povero, Salvatore Sutti, Elisabetta Bugianesi, Ariel E. Feldstein, Emanuele Albano, Massimo Collino & Maurizio Parola. (2017) Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. PLOS ONE 12:3, pages e0172575.
Crossref
Crossref
Kazuyoshi Kon, Kenichi Ikejima, Maki Morinaga, Hiromi Kusama, Kumiko Arai, Tomonori Aoyama, Akira Uchiyama, Shunhei Yamashina & Sumio Watanabe. (2017)
L-carnitine prevents metabolic steatohepatitis in obese diabetic KK-A
y
mice
. Hepatology Research 47:3, pages E44-E54.
Crossref
Crossref
Jake P. Mann, Ariel E. Feldstein & Valerio Nobili. (2017) Update on lipid species and paediatric nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition & Metabolic Care 20:2, pages 110-116.
Crossref
Crossref
James M. Henderson, Hui Emma Zhang, Natasa Polak & Mark D. Gorrell. (2017) Hepatocellular carcinoma: Mouse models and the potential roles of proteases. Cancer Letters 387, pages 106-113.
Crossref
Crossref
Jong Won Kim, Hyejin Yun, Seong-Jin Choi, Sang-Hyub Lee, Surim Park, Chae Woong Lim, Kyuhong Lee & Bumseok Kim. (2017) Evaluating the Influence of Side Stream Cigarette Smoke at an Early Stage of Non-Alcoholic Steatohepatitis Progression in Mice. Toxicological Research 33:1, pages 31-41.
Crossref
Crossref
Ayako Suzuki & Anna Mae Diehl. (2017) Nonalcoholic Steatohepatitis. Annual Review of Medicine 68:1, pages 85-98.
Crossref
Crossref
Latha Paka, David E Smith, Dawoon Jung, Siobhan McCormack, Ping Zhou, Bin Duan, Jing-Song Li, Jiaqi Shi, Yong-Jie Hao, Kai Jiang, Michael Yamin, Itzhak D Goldberg & Prakash Narayan. (2017) Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease. World Journal of Gastroenterology 23:23, pages 4181.
Crossref
Crossref
Kamila Kochan, Edyta Kus, Ewelina Szafraniec, Adrianna Wislocka, Stefan Chlopicki & Malgorzata Baranska. (2017) Changes induced by non-alcoholic fatty liver disease in liver sinusoidal endothelial cells and hepatocytes: spectroscopic imaging of single live cells at the subcellular level. The Analyst 142:20, pages 3948-3958.
Crossref
Crossref
James A. Akingbasote, Alison J. Foster, Huw B. Jones, Rhiannon David, Nigel J. Gooderham, Ian D. Wilson & J. Gerry Kenna. (2017) Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid. Toxicology Research 6:1, pages 81-88.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
3245
3261
.
Hae‐Ki Min, Hitoshi Maruyama, Byoung Kuk Jang, Masahiko Shimada, Faridoddin Mirshahi, Shunlin Ren, Youngman Oh, Puneet Puri & Arun J. Sanyal. (2016) Suppression of IGF binding protein‐3 by palmitate promotes hepatic inflammatory responses. The FASEB Journal 30:12, pages 4071-4082.
Crossref
Crossref
Romeo Papazyan, Zheng Sun, Yong Hoon Kim, Paul M. Titchenell, David A. Hill, Wenyun Lu, Manashree Damle, Min Wan, Yuxiang Zhang, Erika R. Briggs, Joshua D. Rabinowitz & Mitchell A. Lazar. (2016) Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP. Cell Metabolism 24:6, pages 863-874.
Crossref
Crossref
Frank J. Gonzalez, Changtao Jiang & Andrew D. Patterson. (2016) An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease. Gastroenterology 151:5, pages 845-859.
Crossref
Crossref
T. Hang Nghiem-Rao. (2016) Potential Hepatotoxicities of Intravenous Fat Emulsions in Infants and Children. Nutrition in Clinical Practice 31:5, pages 619-628.
Crossref
Crossref
Alessandra Caligiuri, Alessandra Gentilini & Fabio Marra. (2016) Molecular Pathogenesis of NASH. International Journal of Molecular Sciences 17:9, pages 1575.
Crossref
Crossref
Displaying 200 of 290 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list